Walter Ling, M.D.
UCLA Integrated Substance Abuse Programs
5
5
4
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Maureen Hillhouse, Ph.D.
UCLA Integrated Substance Abuse Programs
Shared therapeutic areas:
Worked with same sponsors:
Larissa Mooney, M.D.
UCLA Integrated Substance Abuse Programs
Shared therapeutic areas:
Worked with same sponsors:
Ju-Sheng Zheng, PhD
Westlake University
Shared therapeutic areas:
Elliot Stein, Ph.D.
National Institute on Drug Abuse (NIDA)
Shared therapeutic areas:
Worked with same sponsors:
Sirilak Suksompong, MD
Mahidol University
Shared therapeutic areas:
Jose Carvalho, MD
MOUNT SINAI HOSPITAL
Shared therapeutic areas:
Xiaolong Qi, MD
LanZhou University
Shared therapeutic areas:
Murad Alam, MD
Northwestern University
Shared therapeutic areas:
Madhukar Trivedi, MD
University of Texas Southwestern Medical Center
Shared therapeutic areas:
Worked with same sponsors:
James C Eisenach, MD
Wake Forest University Health Sciences
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
Prometa Pharmacotherapy for Methamphetamine Dependence
Optimizing Outcomes Using Suboxone for Opiate Dependence
Randomized, Double-Blind Cross-Over Trial Of Buprenorphine and Low-Dose Naloxone Versus Buprenorphine
Methylphenidate to Treat Methamphetamine Dependence
Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder
All 5 trials loaded